IGT v. Zynga Inc., Appeal No. 2023-2262 (Fed. Cir. July 22, 2025)
In this week’s Case of the Week, the Federal Circuit examined the reviewability and merits of the Patent Trial Appeal Board’s decision to institute inter...more
Top Brand LLC v. Cozy Comfort Company LLC, Appeal No. 2024-2191 (Fed. Cir. July 17, 2025)
In this week’s Case of the Week, the Court of Appeals for the Federal Circuit held that prosecution history disclaimer applies to...more
7/22/2025
/ Appeals ,
Damages ,
Design Patent ,
JMOL ,
Noninfringement ,
Patent Litigation ,
Patents ,
Prosecution History Estoppel ,
Trademark Infringement ,
Trademark Litigation ,
USPTO
The Regents of the University of California v. The Broad Institute, Inc., Appeal Nos. 2022-1594, -1653 (Fed. Cir. May 12, 2025)
Must an inventor know their invention will work to demonstrate that they “conceived” of it? ...more
This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.
In Incyte Corp. v. Sun Pharm., Judge Hughes entered a dissent pushing back on the...more
5/13/2025
/ Appeals ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Injunctive Relief ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Remand ,
USPTO
In re Forest, Appeal No. 2023-1178 (Fed. Cir. Apr. 3, 2025)
In an appeal from a Patent Office decision denying a patent that would have been expired upon issuance, the Federal Circuit dismissed. Applicant Forest had filed...more
In re: Riggs, Appeal No. 2022-1945 (Fed. Cir. Mar. 24, 2025)
Our Case of the Week explores the power of an examiner to request a rehearing after the Board has entered a decision on an application. The case also relates to...more
4/1/2025
/ America Invents Act ,
Appeals ,
Claim Construction ,
Damages ,
Intellectual Property Protection ,
Judicial Authority ,
Obviousness ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
USPTO ,
Vacated
Actavis Labs. FL, Inc. v. United States, Appeal No. 2023-1320 (Fed. Cir. Mar. 21, 2025)
Our Case of the Week, in the words of its author, Circuit Judge Stark, “is not actually a patent case. It is, instead, a tax case.” In...more
3/25/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Court of Federal Claims ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
USPTO
Apple Inc. v. Gesture Technology Partners, LLC, Appeal Nos. 2023-1475, -1533 (Fed. Cir. Mar. 4, 2025)
Our Case of the Week is a high-stakes appeal from an inter partes review concerning a patent titled “Camera Based...more
3/11/2025
/ Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Remand ,
Technology ,
USPTO ,
Vacated
LKQ Corporation v. GM Global Technology Operations LLC, Appeal No. 2021-2348 (Fed. Cir. May 21, 2024) -
In a rare en banc opinion, the Federal Circuit overruled decades of prior precedent concerning the standard to...more
5/29/2024
/ Appeals ,
Attorney's Fees ,
Design Patent ,
En Banc Review ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Patents ,
Prior Art ,
SCOTUS ,
Summary Judgment ,
USPTO ,
Utility Patents
Luv N’ Care, Ltd. v. Lindsey Laurain, Appeal Nos. 2022-1905, -1970 (Fed. Cir. Apr.12, 2024) -
In this week’s Case of the Week, the Federal Circuit affirmed the district court’s bench trial decision that unclean hands...more
4/16/2024
/ Abbreviated New Drug Application (ANDA) ,
Attorney's Fees ,
Bench Trial ,
Design Patent ,
Food and Drug Administration (FDA) ,
Inequitable Conduct ,
Injunctions ,
Misleading Statements ,
Patent Applications ,
Patent Infringement ,
Patent Invalidity ,
Prior Art ,
Trade Dress ,
USPTO ,
Willful Misconduct
Roku, Inc. v. International Trade Commission, Appeal No. 2022-1386 (Fed. Cir. Jan. 19, 2024)
In an appeal from the International Trade Commission (the “Commission”), the Federal Circuit addressed a number of findings...more
Purdue Pharma L.P. v. Collegium Pharmaceutical, Inc. (United States Patent and Trademark Office intervening), Appeal No. 2022-1482 (Fed. Cir. Nov. 21, 2023)
In the Federal Circuit’s only precedential patent opinion last...more
Allgenesis Biotherapeutics Inc. v. Cloudbreak Therapeutics, LLC, Appeal No. 2022-1706 (Fed. Cir. Nov. 7, 2023)
In this week’s Case of the Week, the Federal Circuit dismissed appellant Allgenesis’s appeal of an inter...more
11/14/2023
/ Appeals ,
Dismissals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Intrinsic Evidence ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Remand ,
USPTO
Finjan LLC v. SonicWall, Inc., Appeal No. 2022-1048 (Fed. Cir. Oct. 13, 2023)
In the Federal Circuit’s only precedential opinion this week, a majority affirmed summary judgment of non-infringement on appellant Finjan’s...more
10/17/2023
/ Appeals ,
Collateral Estoppel ,
Digital Downloads ,
Indefiniteness ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Summary Judgment ,
USPTO
Sisvel International S.A. v. Sierra Wireless, Inc., Appeal Nos. 2022-1493, -1547 (Fed. Cir. Oct. 6, 2023)
Our Case of the Week falls in a series of cases concerning patents that claim a means for performing a particular...more
In re Cellect, LLC, Appeal Nos. 2022-1293, -1294, -1295, -1296 (Fed. Cir. Aug. 28, 2023)
In a significant appeal from ex parte reexamination proceedings before the Patent Trial and Appeal Board, the Federal Circuit...more
9/6/2023
/ Appeals ,
Claim Construction ,
Ex Partes Reexamination ,
Final Written Decisions ,
Motion to Amend ,
Patent Litigation ,
Patent Ownership ,
Patent Term Adjustment ,
Patent Term Extensions ,
Patent Terms ,
Patent Trial and Appeal Board ,
Patents ,
USPTO
Volvo Penta of the Americas, LLC v. Brunswick Corp., Appeal No. 2022-1765 (Fed. Cir. Aug. 24, 2023)
In its only precedential patent case of the week, the Federal Circuit held the Patent Trial and Appeal Board erred in...more
Axonics, Inc. v. Medtronic, Inc., Appeal Nos. 2022-1532, -1533 (Fed. Cir. Aug. 7, 2023)
In this week’s case of the week, the Federal Circuit re-affirmed existing precedent that in inter partes review proceedings before...more
8/15/2023
/ Appeals ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
USPTO ,
Vacated
United Therapeutics Corporation v. Liquidia Technologies, Inc., Appeal Nos. 2022-2217, 2023-1021 (Fed. Cir. July 24, 2023)
In the Federal Circuit’s only precedential patent case this week, the Court considered questions...more
8/1/2023
/ Amgen v Sanofi ,
Appeals ,
Genus ,
Hatch-Waxman ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
SCOTUS ,
Section 112 ,
USPTO ,
Written Descriptions
Apple Inc. v. Vidal, Appeal No. 2022-1249 (Fed. Cir. Mar. 13, 2023)
In our Case of the Week, the Federal Circuit allowed Apple’s challenge to the Patent Trial and Appeal Board’s (“PTAB”) Fintiv rules to proceed, at least...more
3/21/2023
/ Administrative Procedure Act ,
Appeals ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Noninfringement ,
Notice and Comment ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Remand ,
Rulemaking Process ,
USPTO
Regents of the University of Minnesota v. Gilead Sciences, Inc., Appeal No. 21-2168 (Fed. Cir. Mar. 6, 2023)
The Federal Circuit’s only precedential patent opinion this week focuses on the written description requirement...more
3/14/2023
/ Administrative Procedure Act ,
Anticipation ,
Appeals ,
Inter Partes Review (IPR) Proceeding ,
Patent Applications ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Sovereign Immunity ,
USPTO ,
Written Descriptions
This week, we provide extensive write-ups about two consequential decisions issued by the United States Court of Appeals for the Federal Circuit concerning two procedural issues under the America Invents Act (“AIA”), both...more
8/23/2022
/ America Invents Act ,
Appeals ,
Declaratory Relief ,
Inter Partes Review (IPR) Proceeding ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
SCOTUS ,
Thryv Inc v Click-To-Call Technologies LP ,
United States v Arthrex Inc ,
USPTO
Mitek Systems, Inc. v. United Services Automobile Association, Appeal No. 2021-1989 (Fed. Cir. May 20, 2022) -
Our Case of the Week this week is a declaratory judgment action brought against USAA. In a 27-page opinion,...more
5/24/2022
/ Appeals ,
Article III ,
Constitutional Challenges ,
Declaratory Judgments ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Remand ,
Reversal ,
Subject Matter Jurisdiction ,
USPTO ,
Venue
Hunting Titan, Inc. v. DynaEnergetics Europe GMBH, Appeal Nos. 2020-2163, -2191 (Fed. Cir. March 24, 2022) -
In a notable review of the USPTO’s new Precedential Opinions Panel, the Federal Circuit discussed the...more
3/29/2022
/ Claim Construction ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Means-Plus-Function ,
Motion to Amend ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Precedential Opinion ,
Remand ,
USPTO
Teva Pharms. Int’l GmbH v. Eli Lilly and Co., Appeal Nos. 2020-1747, -1748, -1750 (Fed. Cir. Aug. 16, 2021) -
Eli Lilly and Co. v. Teva Pharms. Int’l GmbH, Appeal Nos. 2020-1876, -1877, -1878 (Fed. Cir. Aug. 16, 2021)...more